I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
A. Lutckii A
14
results:
Search for persons
X
Format
Online (14)
Mediatypes
Articles (Online) (3)
OpenAccess-fulltext (11)
Languages
english (4)
russian (10)
Sorted by: Relevance
Sorted by: Year
?
1
Totally drug‐resistant tuberculosis and adjunct therapies:
Parida, S. K.
;
Axelsson‐Robertson, R.
;
Rao, M. V.
...
Journal of Internal Medicine. 277 (2014) 4 - p. 388-405 , 2014
Link:
https://doi.org/10.1111/..
?
2
The efficacy and safety of levilimab in severely ill COVID-..:
Lomakin, Nikita V.
;
Bakirov, Bulat A.
;
Protsenko, Denis N.
...
Inflammation Research. 70 (2021) 10-12 - p. 1233-1246 , 2021
Link:
https://doi.org/10.1007/..
?
3
Lack of Association Between Interleukin 28B Polymorphism an..:
Psaros Einberg, Afrodite
;
Duberg, Ann-Sofi
;
Filipovich, Olga
...
Journal of Pediatric Gastroenterology & Nutrition. 65 (2017) 6 - p. 608-612 , 2017
Link:
https://doi.org/10.1097/..
?
4
Efficacy and safety of levilimab in combination with methot..:
V. I. Mazurov
;
A. M. Lila
;
M. A. Korolev
...
https://rsp.mediar-press.net/rsp/article/view/3284. , 2023
Link:
https://doi.org/10.47360..
?
5
Efficacy and safety of levilimab in combination with methot..:
V. I. Mazurov
;
A. M. Lila
;
M. A. Korolev
...
https://rsp.mediar-press.net/rsp/article/view/3284/2262. , 2023
Link:
https://rsp.mediar-press..
?
6
Levilimab clinical efficacy for interleukin-6 receptor inhi..:
N. V. Lomakin
;
B. A. Bakirov
;
G. H. Musaev
...
https://www.biopreparations.ru/jour/article/view/443. , 2022
Link:
https://doi.org/10.30895..
?
7
Levilimab clinical efficacy for interleukin-6 receptor inhi..:
N. V. Lomakin
;
B. A. Bakirov
;
G. H. Musaev
...
https://www.biopreparations.ru/jour/article/view/443/592. , 2022
Link:
https://www.biopreparati..
?
8
Effectiveness and safety of levilimab in combination with m..:
V. I. Mazurov
;
M. A. Korolev
;
A. M. Prystrom
...
https://mrj.ima-press.net/mrj/article/view/1164/1141. , 2021
Link:
https://mrj.ima-press.ne..
?
9
Efficacy and safety of levilimab in combination with methot..:
V. I. Mazurov
;
E. G. Zotkin
;
I. Z. Gaydukova
...
https://rsp.mediar-press.net/rsp/article/view/3016. , 2021
Link:
https://doi.org/10.47360..
?
10
Efficacy and safety of levilimab in combination with methot..:
V. Mazurov I
;
E. Zotkin G
;
I. Gaydukova Z
...
https://rsp.mediar-press.net/rsp/article/view/3016/2074. , 2021
Link:
https://rsp.mediar-press..
?
11
Effectiveness and safety of levilimab in combination with m..:
V. I. Mazurov
;
M. A. Korolev
;
A. M. Prystrom
...
https://mrj.ima-press.net/mrj/article/view/1164. , 2021
Link:
https://doi.org/10.14412..
?
12
Interferon-γ: biological function and application for study..:
A. Lutckii A
;
A. Zhirkov A
;
D. Lobzin Yu
...
https://journal.niidi.ru/jofin/article/view/438/421. , 2016
Link:
https://journal.niidi.ru..
?
13
Interferon-γ: biological function and application for study..:
A. A. Lutckii
;
A. A. Zhirkov
;
D. Yu. Lobzin
...
https://journal.niidi.ru/jofin/article/view/438. , 2016
Link:
https://doi.org/10.22625..
?
14
The efficacy and safety of levilimab in severely ill COVID-..:
Lomakin, Nikita V
;
Bakirov, Bulat A
;
Protsenko, Denis N
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479713/. , 2021
Link:
http://www.ncbi.nlm.nih...
1-14